Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     General & Plastic Surgery    

Global Ablation Devices Market

PRODUCT TITLE PUBLISHED
Asia-Pacific Ultrasound Ablation Asia-Pacific Ultrasound Ablation
The Asia-Pacific Ultrasound Ablation Market was pegged at $259 million in 2013 and expected to be $535 million by 2018. The key players in Asia-Pacific Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
European Ultrasound Ablation European Ultrasound Ablation
The European Ultrasound Ablation Market was pegged at $286 million in 2013 and expected to be $500 million by 2018. The key players in European Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Americas Thermal Ablation Americas Thermal Ablation
The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Upcoming
Asia-Pacific Thermal Ablation Asia-Pacific Thermal Ablation
The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Thermal Ablation European Thermal Ablation
The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Americas Electrical Ablators Americas Electrical Ablators
The electrical ablation market of the Americas, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $387 million in 2013 and is expected to reach $480 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
Asia-Pacific Electrical Ablators Asia-Pacific Electrical Ablators
The Asia-Pacific electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $159 million in 2013 and is expected to reach $236 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Electrical Ablators European Electrical Ablators
The European electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $189 million in 2013 and is expected to reach $228 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Brachytherapy European Brachytherapy
The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Brachytherapy Asia-Pacific Brachytherapy
The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Brachytherapy Americas Brachytherapy
The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
51 reports | Show
Connect With Us
US/CAN : +1-888-502-0539